OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 04:27:03 2024-05-24 EDT | ||
| 1.23 EUR | -6.82% |
|
| Current month | +12.82% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 1.23 | -6.82% |
| 24-05-23 | 1.32 | -6.38% |
| 24-05-22 | 1.41 | -4.08% |
| 24-05-21 | 1.47 | -8.70% |
| 24-05-20 | 1.61 | +10.27% |
Real-time BOERSE MUENCHEN
Last update May 24, 2024 at 04:27 am
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GG7EF0 |
| ISIN | DE000GG7EF01 |
| Date issued | 2024-04-23 |
| Strike | 128.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.32 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.61 € |
|---|---|
| Lowest since issue | 0.78 € |
| Spread | 0.05 € |
| Spread % | 4.03% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
140
USD
Average target price
146.8
USD
Spread / Average Target
+4.83%
- Stock Market
- Certificates
- Certificat
